Microfluidics Market by Material Application - Global Forecast to 2020

The global microfluidics market is expected to grow at a significant CAGR of around 19% during the forecast period (2015 to 2020). The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals in clinical laboratories, and high prices of integrated instruments and microfluidics chips are hampering the growth of this market to a certain extent.

In this report, the global microfluidics market is segmented on the basis of materials and applications. On the basis of applications, the microfluidics market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further divided into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics segment is categorized into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. The drug delivery segment is subsegmented into inhalers, microneedles, and micropumps. On the basis of materials, the microfluidics market is divided into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. In addition, country-wise segmentation of each region (North America, Europe, Asia-Pacific, and the Rest of the World) is also provided in the report.

The in vitro diagnostics application segment accounted for a major share of the microfluidics market. This market is primarily driven by the rising demand for point-of-care testing, rising incidences of lifestyle disorders and diseases, growing geriatric population, and rapidly improving healthcare infrastructure in Asian countries. 

In 2014, North America accounted for the largest share to the global microfluidics market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global microfluidics market is highly fragmented; some of the major players in this market are Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

Reasons to Buy the Report 

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microfluidics market. The report analyzes the microfluidics market by material and application across all regions

• Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the microfluidics market

• Market Development: Comprehensive information on the lucrative emerging markets by material, application, and region

• Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the microfluidics market

• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the microfluidics market

1 INTRODUCTION 18

1.1 OBJECTIVES OF THE STUDY 18

1.2 MARKET DEFINITION 18

1.3 MARKET SCOPE 18

1.3.1 MARKETS COVERED 19

1.3.2 YEARS CONSIDERED FOR THE STUDY 19

1.4 CURRENCY AND PRICING 19

1.5 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21

2.1 RESEARCH APPROACH 21

2.2 MARKET SIZE ESTIMATION 23

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25

2.4 MARKET SHARE ESTIMATION 26

2.4.1 KEY DATA FROM SECONDARY SOURCES 26

2.4.2 KEY DATA FROM PRIMARY SOURCES 27

2.4.3 KEY INDUSTRY INSIGHTS 28

2.5 ASSUMPTIONS FOR THE STUDY 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 35

4.1 MICROFLUIDICS MARKET OVERVIEW 35

4.2 ASIA-PACIFIC MICROFLUIDICS MARKET, BY MATERIAL 36

4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 37

4.4 MICROFLUIDICS MARKET: GEOGRAPHIC MIX 38

4.5 MICROFLUIDICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 39

5 MARKET OVERVIEW 40

5.1 INTRODUCTION 41

5.2 MARKET SEGMENTATION 41

5.2.1 BY MATERIAL 41

5.2.2 BY APPLICATION 41

5.3 KEY MARKET DYNAMICS 42

5.3.1 MARKET DRIVERS 43

5.3.1.1 Rising demand for point-of-care (POC) testing 43

5.3.1.2 Faster returns on investment 44

5.3.1.3 Faster testing and improved portability through microfluidic chip miniaturization 44

5.3.2 MARKET RESTRAINTS 45

5.3.2.1 Incorporation of microfluidics technology into existing workflows 45

5.3.2.2 Complex and time-consuming regulatory approval process 45

5.3.3 MARKET OPPORTUNITIES 46

5.3.3.1 Growing Asian market 46

5.3.3.2 Expanding applications of drug delivery technologies 47

5.3.4 MARKET CHALLENGES 47

5.3.4.1 Lack of market visibility for microfluidics products 48

5.3.4.2 High prices of integrated instruments and microfluidic sensors 48

6    INDUSTRY INSIGHTS 49

6.1 INTRODUCTION 49

6.2 VALUE CHAIN ANALYSIS 49

6.3 INDUSTRY TRENDS 51

6.3.1 SHIFTING TREND TOWARDS POLYMERS ADOPTION 52

6.3.2 UNIVERSITIES ACTIVELY GENERATING MICROFLUIDIC STARTUPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS 52

7 MICROFLUIDICS MARKET, BY MATERIAL 54

7.1 INTRODUCTION 55

7.2 POLYMER-BASED MICROFLUIDICS 57

7.3 GLASS-BASED MICROFLUIDICS 58

7.4 SILICON-BASED MICROFLUIDICS 59

7.5 OTHER MATERIAL-BASED MICROFLUIDICS 60

8 GLOBAL MICROFLUIDICS MARKET, BY APPLICATION 61

8.1 INTRODUCTION 62

8.2 IN VITRO DIAGNOSTICS 63

8.2.1 POINT-OF-CARE TESTING 65

8.2.2 CLINICAL DIAGNOSTICS 66

8.2.3 AGRO FOOD TESTING 67

8.2.4 INDUSTRIAL TESTING 68

8.2.5 ENVIRONMENTAL TESTING 70

8.3 PHARMACEUTICAL RESEARCH 71

8.3.1 LAB ANALYTICS 73

8.3.1.1 Proteomic analysis 75

8.3.1.2 Genomics analysis 76

8.3.1.3 Cell-based assays 77

8.3.1.4 Capillary electrophoresis 78

8.3.2 MICRODISPENSING 79

8.3.3 MICROREACTION 80

 

8.4 DRUG DELIVERY 82

8.4.1 INHALERS 84

8.4.2 MICROPUMPS 85

8.4.3 MICRONEEDLES 86

9 GLOBAL MICROFLUIDICS MARKET, BY REGION 87

9.1 INTRODUCTION 88

9.2 NORTH AMERICA 90

9.2.1 U.S. 95

9.2.2 CANADA 98

9.3 EUROPE 102

9.3.1 GERMANY 106

9.3.2 FRANCE 109

9.3.3 U.K. 112

9.3.4 ITALY 115

9.3.5 SPAIN 118

9.3.6 REST OF EUROPE 122

9.4 ASIA-PACIFIC 125

9.4.1 JAPAN 130

9.4.2 CHINA 133

9.4.3 INDIA 136

9.4.4 REST OF ASIA-PACIFIC 139

9.5 REST OF THE WORLD (ROW) 143

9.5.1 LATIN AMERICA 146

9.5.2 MIDDLE EAST AND AFRICA 149

10 COMPETITIVE LANDSCAPE 153

10.1 OVERVIEW 153

10.2 COMPETITIVE SITUATIONS AND TRENDS 154

10.2.1 NEW PRODUCT LAUNCHES 154

10.2.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 155

10.2.3 EXPANSIONS 156

10.2.4 MERGERS AND ACQUISITIONS 156

11 COMPANY PROFILES 158

11.1 INTRODUCTION 158

11.2 THERMO FISHER SCIENTIFIC, INC. 159

11.2.1 BUSINESS OVERVIEW 159

11.2.2 PRODUCT OFFERINGS 160

11.2.3 RECENT DEVELOPMENTS 160

11.2.4 MNM VIEW 160

 

11.3 BECTON, DICKINSON AND COMPANY 161

11.3.1 BUSINESS OVERVIEW 161

11.3.2 PRODUCT OFFERINGS 162

11.3.3 RECENT DEVELOPMENTS 162

11.3.4 MNM VIEW 162

11.4 BIO-RAD LABORATORIES, INC. 163

11.4.1 BUSINESS OVERVIEW 163

11.4.2 PRODUCT OFFERINGS 164

11.4.3 RECENT DEVELOPMENTS 164

11.4.4 MNM VIEW 164

11.5 PERKINELMER, INC. 165

11.5.1 BUSINESS OVERVIEW 165

11.5.2 PRODUCT OFFERINGS 166

11.5.3 RECENT DEVELOPMENTS 166

11.5.4 MNM VIEW 167

11.6 AGILENT TECHNOLOGIES, INC. 168

11.6.1 BUSINESS OVERVIEW 168

11.6.2 PRODUCT OFFERINGS 169

11.6.3 RECENT DEVELOPMENTS 169

11.6.4 MNM VIEW 170

11.7 DANAHER CORPORATION 171

11.7.1 BUSINESS OVERVIEW 171

11.7.2 PRODUCT OFFERINGS 172

11.7.3 RECENT DEVELOPMENTS 172

11.8 CEPHEID INC. 173

11.8.1 BUSINESS OVERVIEW 173

11.8.2 PRODUCT OFFERINGS 174

11.8.3 RECENT DEVELOPMENTS 174

11.9 FLUIDIGM CORPORATION 175

11.9.1 BUSINESS OVERVIEW 175

11.9.2 PRODUCT OFFERINGS 176

11.9.3 RECENT DEVELOPMENTS 176

11.10 ROCHE DIAGNOSTICS LTD. 177

11.10.1 BUSINESS OVERVIEW 177

11.10.2 PRODUCT OFFERINGS 177

11.10.3 RECENT DEVELOPMENTS 178

11.11 ILLUMINA, INC. 179

11.11.1 BUSINESS OVERVIEW 179

11.11.2 PRODUCT OFFERINGS 180

11.11.3 RECENT DEVELOPMENTS 180

12 APPENDIX 181

12.1 INSIGHTS OF INDUSTRY EXPERTS 181

12.2 DISCUSSION GUIDE 182

12.3 ADDITIONAL DEVELOPMENTS, 2012–2015 186

12.4 AVAILABLE CUSTOMIZATIONS 188

12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 189

12.6 RELATED REPORTS 191